Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.

Ibrahim, Asmaa; Toss, Michael S; Makhlouf, Shorouk; Miligy, Islam M; Minhas, Fayyaz; Rakha, Emad A

Ibrahim, Asmaa; Toss, Michael S; Makhlouf, Shorouk; Miligy, Islam M; Minhas, Fayyaz; Rakha, Emad A.

Afiliação

Ibrahim A; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Toss MS; Histopathology department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Makhlouf S; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Miligy IM; Academic Unit for Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, UK.
Minhas F; Department of Pathology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Rakha EA; Histopathology department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt.

Histopathology ; 82(3): 393-406, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36349500

Assuntos

Neoplasias da Mama; Humanos; Feminino; Amarelo de Eosina-(YS); Índice Mitótico/métodos; Neoplasias da Mama/diagnóstico; Hematoxilina; Reprodutibilidade dos Testes; Biomarcadores Tumorais/análise; Imuno-Histoquímica; Mitose; Anticorpos; Fosforilação

Palavras-chave

Breast cancer; WSI; count; mitosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Histopathology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google